Yunsong Cui and Dr. Ellen Sweeney will be representing Atlantic PATH, one of the CanPath regional cohorts, with their posters and lightning session presentations at the Canadian Cancer Research Conference.

Yunsong Cui, MSc, is the Data Analyst at Atlantic PATH, Faculty of Medicine, Dalhousie University. He performs statistical analyses of health outcomes using data from Atlantic PATH, patient registries and administrative health databases. His primary research interests include physical activity, lifestyle, diet, and environmental factors related to cancer and comorbidities. His work at Atlantic PATH involves projects on cancer, inflammatory bowel disease, cardiovascular disease, environmental exposures, and polypharmacy.

Yunsong will be presenting a poster on depression, anxiety and the risk of cancer from the Psychosocial Factors and Cancer Incidence (PSY-CA) consortium, which includes data from 18 longitudinal cohorts in the Netherlands, United Kingdom and Canada, including Atlantic PATH, CARTaGENE (Quebec) and the Ontario Health Study (n = 617,355). Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12, from 12:00–1:30 pm AST and Monday, November 13, from 1:10–2:40 pm AST. Yunsong will also present on the PSY-CA study in the lightning session in a panel on Cancer Risk and Primary Prevention on Tuesday, November 14, at 10:40 am AST.

Dr. Ellen Sweeney is the Research Director at Atlantic PATH, Faculty of Medicine, Dalhousie University; Associate Member, Beatrice Hunter Cancer Research Institute; Affiliate Scientist, Nova Scotia Health; Scholar, Healthy Populations Institute, Dalhousie University; and Adjunct Professor, Faculty of Graduate Studies, Dalhousie University. Dr. Sweeney’s background is in environmental health and breast cancer. She is the primary contact for data access and leads the environmental and occupational health research streams at Atlantic PATH.

Dr. Sweeney will present a poster on exploring environmental exposure to arsenic and cancer risk in Atlantic PATH using toxicological and machine learning methods, as well as one on the mental health status of prostate cancer survivors in the Atlantic PATH cohort. Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12, from 12:00–1:30 pm AST and Monday, November 13, from 1:10–2:40 pm AST. Dr. Sweeney will also present the mental health and prostate cancer study in the lightning session in a panel on Cancer Survivorship on Sunday, November 12, at 1:30 pm AST.